drugset / Trial / NCT02830906

Effect of Ramosetron in Prevention of Intrathecal Morphine Induced Nausea and Vomiting

NCT02830906

Phase 3 Completed 99 enrolled Thammasat University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

We would like to know the prophylactic anti-emetic effect of ramosetron compare to ondansetron in patient undergone total knee arthroplasty with spinal anesthesia and intrathecal morphine .

Timeline

Start
2014-04
Primary completion
2015-02
Completion
2015-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ondansetron Other / unclassified 8 mg Intravenous
Subject Ramosetron Small molecule 0.3 mg Intravenous

Indications

No indication recorded.